Corvidia Therapeutics to Participate in 38th Annual J.P. Morgan Healthcare ConferenceHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Corvidia Therapeutics to Participate in 38th Annual J.P. Morgan Healthcare ConferencePR NewswireJanuary 8, 2020ReblogShareTweetShareWALTHAM, Mass., Jan. 8, 2020 /PRNewswire/ -- Corvidia Therapeutics Inc., a clinical stage company focused on the research, development and commercialization of transformative therapies in cardio-renal disease, today announced the company will present at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14 at 2:30 pm. Details: Location: Westin St. Francis Hotel, San Francisco, CA Presentation Room: Elizabethan DDate/Time: Tuesday, January 14 at 2:30pm PSTAbout Corvidia Therapeutics Inc.Corvidia Therapeutics is a clinical stage company focused on the research, development and commercialization of transformative therapies for cardio-renal diseases. The Company is currently developing potential treatments for atherosclerotic cardiovascular disease (ASCVD) and inflammation in chronic kidney disease (CKD) patients, and high triglyceride-induced acute pancreatitis (AP). Founded in 2015, Corvidia Therapeutics is headquartered in Waltham, Massachusetts. Learn more at: www.corvidiatx.com.Press Inquiries:McDougall Communications on behalf of Corvidia Therapeutics Inc.Elizabeth Harness, elizabeth@mcdougallpr.com, Tel: +1 (585) 435-7379 Christopher Knospe, chris@mcdougallpr.com, Tel: +1 (716) 440-5580CisionMoreView original content:http://www.prnewswire.com/news-releases/corvidia-therapeutics-to-participate-in-38th-annual-jp-morgan-healthcare-conference-300983087.htmlSOURCE Corvidia Therapeutics Inc.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read Next/C O R R E C T I O N -- National Kidney Foundation/PR NewswireBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoUS patient with coronavirus of unknown origin denied test for daysAFPMost face masks won’t protect you from the coronavirusYahoo Finance'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoKorea Cases Top 2,000; Nigeria Confirms Infection: Virus UpdateBloombergRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinancePersonal loans growth rate rises, impacts retailersYahoo Finance Video